文献速递膀胱癌与上尿路尿路上皮癌

机器人辅助根治性膀胱切除术与开放根治性膀胱切除术:基于随机对照试验的围手术期、肿瘤学及生活质量结局的系统综述与Meta分析

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials.
PubMed 文献 · Eur Urol · 2023-05-09

该系统综述与Meta分析纳入8项随机对照试验共1024例膀胱癌患者,比较机器人辅助与开放根治性膀胱切除术的围手术期、肿瘤学及生活质量结局。结果显示机器人辅助手术与更短住院时间、更少出血和输血及更低血栓栓塞事件相关,但手术时间更长,肿瘤学结局无差异,总体健康相关生活质量无改善。

要点

  • 机器人辅助根治性膀胱切除术较开放手术住院时间更短、出血和输血更少、血栓栓塞事件更少。
  • 开放手术手术时间更短,但淋巴结检出数和切缘阳性率两组无差异。
  • 机器人辅助手术在身体功能和角色功能方面更优,但总体健康相关生活质量无改善,生存结局无差异。

核心结论

  • 机器人辅助根治性膀胱切除术较开放手术提供多种围手术期获益。
  • 对于希望避免输血、希望缩短住院时间或血栓栓塞事件高风险的患者,机器人辅助手术可能更合适。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase、Web of Science和clinicaltrials.gov至2022年5月31日,纳入8项随机对照试验共1024例参与者。

主要发现

  • 机器人辅助手术与更短住院时间相关(均数差0.21,95%CI 0.03-0.39,p=0.02),并发症发生率与开放手术相似。
  • 开放手术与更高血栓栓塞事件相关(OR 1.84,95%CI 1.02-3.31,p=0.04)。
  • 开放手术出血量更多(均数差322 ml,95%CI 193-450,p<0.001)且输血更多(OR 2.35,95%CI 1.65-3.36,p<0.001),但手术时间更短(均数差76分钟,95%CI 39-112,p<0.001)。
  • 淋巴结检出数(均数差1.07,95%CI -1.73至3.86,p=0.5)和切缘阳性率(OR 0.95,95%CI 0.54-1.67,p=0.9)无差异。
  • 机器人辅助手术与更好的身体功能或幸福感(标准化均数差0.47,95%CI 0.29-0.65,p<0.001)和角色功能(均数差8.8,95%CI 2.4-15.1,p=0.007)相关,但总体健康相关生活质量无改善;无进展生存期和总生存期无差异。

临床怎么用

  • 作者认为机器人辅助根治性膀胱切除术可能更适用于希望避免输血、希望缩短住院时间或血栓栓塞事件高风险的患者。

局限性

  • 局限性可能包括试验患者缺乏普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Differences in recovery, oncological, and quality of life (QoL) outcomes between open radical cystectomy (ORC) and robot-assisted radical cystectomy (RARC) for patients with bladder cancer are unclear. OBJECTIVE: This review aims to compare these outcomes within randomized trials of ORC and RARC in this context. The primary outcome was the rate of 90-d perioperative events. The secondary outcomes included operative, pathological, survival, and health-related QoL (HRQoL) measures. EVIDENCE ACQUISITION: Systematic literature searches of MEDLINE, Embase, Web of Science, and clinicaltrials.gov were performed up to May 31, 2022. EVIDENCE SYNTHESIS: Eight trials, reporting 1024 participants, were included. RARC was associated with a shorter hospital length of stay (LOS; mean difference [MD] 0.21, 95% confidence interval [CI] 0.03-0.39, p = 0.02) than and similar complication rates to ORC. ORC was associated with higher thromboembolic events (odds ratio [OR] 1.84, 95% CI 1.02-3.31, p = 0.04). ORC was associated with more blood loss (MD 322 ml, 95% CI 193-450, p < 0.001) and transfusions (OR 2.35, 95% CI 1.65-3.36, p < 0.001), but shorter operative time (MD 76 min, 95% CI 39-112, p < 0.001) than RARC. No differences in lymph node yield (MD 1.07, 95% CI -1.73 to 3.86, p = 0.5) or positive surgical margin rates (OR 0.95, 95% CI 0.54-1.67, p = 0.9) were present. RARC was associated with better physical functioning or well-being (standardized MD 0.47, 95% CI 0.29-0.65, p < 0.001) and role functioning (MD 8.8, 95% CI 2.4-15.1, p = 0.007), but no improvement in overall HRQoL. No differences in progression-free survival or overall survival were seen. Limitations may include a lack of generalization given trial patients. CONCLUSIONS: RARC offers various perioperative benefits over ORC. It may be more suitable in patients wishing to avoid blood transfusion, those wanting a shorter LOS, or those at a high risk of thromboembolic events. PATIENT SUMMARY: This study compares robot-assisted keyhole surgery with open surgery for bladder cancer. The robot-assisted approach offered less blood loss, shorter hospital stays, and fewer blood clots. No other differences were seen.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Khetrapal P, Wong JKL, Tan WP, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials. Eur Urol. 2023. PMID: 37169638. doi:10.1016/j.eururo.2023.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。